All admissions had type 2 diabetes, 64% an HbA1c > 53 mmol/mol (n = 57, 64%), 75.3% were prescribed oral anti-diabetes medication (including 16.9% SGLT2 Inhibitors) and 48.3% were prescribed insulin. Here, SLC5A2 is linked to type 2 diabetes mellitus.